Takeda Pharmaceutical TAK Earnings Call Transcripts

NYSE TAK
$21.01 -0.19 (-0.90%)
At close: Nov 6, 2026 · 4:00 PM EST
4 earnings calls on file for Takeda Pharmaceutical, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Takeda Pharmaceutical Q2 2026 Earnings Call

Oct 29, 2026 9,913 words · 43 min read
  • Christopher David O'ReillyHead of IR
  • Julie KimPresident and CEO
  • Milano FurutaChief Financial Officer
  • Andy PlumpR&D President
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Takeda Pharmaceutical Earnings Call Transcripts

Calls4
LatestOct 29, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2019

All 4 Takeda Pharmaceutical transcripts Register to get access to Takeda Pharmaceutical’s earnings call transcripts.